Ernexa Therapeutics Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: ERNA
Ernexa Therapeutics Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ERNA. It has reported private securities offerings to the US SEC, most recently $7.2 million sold in a notice filed in 2025.
Ernexa Therapeutics at a glance
What does Ernexa Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $7.2 million sold (2025).
Frequently asked questions about Ernexa Therapeutics
Where is Ernexa Therapeutics headquartered?
Ernexa Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Ernexa Therapeutics do?
Ernexa Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Ernexa Therapeutics a public company?
Yes. Ernexa Therapeutics Inc. trades on Nasdaq under the ticker ERNA.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences